Electronic patient self-Reporting of Adverse-events: Patient Information and aDvice (eRAPID): A randomised controlled trial in systemic cancer treatment

The system can generate alerts to clinical teams for severe AE and provides patient advice on managing mild AEs. The overall aims of eRAPID are to improve the safe delivery of cancer treatments, enhance patient care and standardise AE documentation.